Clinical TrialsRisvutatug Rezetecan Improves Survival in Phase III ARTEMIS-008 Trial, Mark... Risvutatug Rezetecan Improves Survival in Phase III ARTEMIS-008 Trial, Mark... Read Post »
New Drug ApprovalSanofi Wins US FDA Approval for Subcutaneous Sarclisa Escena, First Cancer ... Sanofi Wins US FDA Approval for Subcutaneous Sarclisa Escena, First Cancer ... Read Post »
Clinical TrialsRoche Discontinues Tominersen and RG6496 Development for Huntington’s... Roche Discontinues Tominersen and RG6496 Development for Huntington’s... Read Post »
Clinical TrialsForte Reports Positive Phase 1b Results for FB102 in Vitiligo Forte Reports Positive Phase 1b Results for FB102 in Vitiligo Read Post »
ResearchISSCR Reports 12-Month STEM-PD Trial Findings in Parkinson’s Disease ISSCR Reports 12-Month STEM-PD Trial Findings in Parkinson’s Disease Read Post »
Clinical TrialsLEO Pharma Reports Positive Phase II TRAPEDS-1 Data Supporting Long-Term Sa... LEO Pharma Reports Positive Phase II TRAPEDS-1 Data Supporting Long-Term Sa... Read Post »
Clinical TrialsFate Therapeutics Wins FDA IND Clearance for FT839 Dual-CAR T-Cell Therapy ... Fate Therapeutics Wins FDA IND Clearance for FT839 Dual-CAR T-Cell Therapy ... Read Post »
Clinical TrialsIpsen Reports Positive Phase III BEOND Results for Dysport in Episodic and ... Ipsen Reports Positive Phase III BEOND Results for Dysport in Episodic and ... Read Post »
Clinical TrialsINmune Bio Reports Early MRI Evidence of XPro Activity in Phase 2 Alzheimer... INmune Bio Reports Early MRI Evidence of XPro Activity in Phase 2 Alzheimer... Read Post »
Clinical TrialsBiocytogen, Whitehawk Partner to Develop Bispecific Antibody-Drug Conjugate... Biocytogen, Whitehawk Partner to Develop Bispecific Antibody-Drug Conjugate... Read Post »
Clinical TrialsBiocon Reports New Phase III Evidence for Yesafili Biosimilar Biocon Reports New Phase III Evidence for Yesafili Biosimilar Read Post »
Clinical TrialsAstraZeneca, Ionis’ Wainua Misses Phase III Endpoint in ATTR-CM Trial AstraZeneca, Ionis’ Wainua Misses Phase III Endpoint in ATTR-CM Trial Read Post »
Clinical TrialsSatellos Reports Interim Phase 2 TRAILHEAD Data: SAT‑3247 Shows Muscle Co... Satellos Reports Interim Phase 2 TRAILHEAD Data: SAT‑3247 Shows Muscle Co... Read Post »
Clinical TrialsRhythm Reports NEJM Publication of IMCIVREE Trial in Hypothalamic Obesity Rhythm Reports NEJM Publication of IMCIVREE Trial in Hypothalamic Obesity Read Post »
Clinical TrialsPrilenia Launches Global Phase 3 PRECISE-HD Trial of Pridopidine for Huntin... Prilenia Launches Global Phase 3 PRECISE-HD Trial of Pridopidine for Huntin... Read Post »
Clinical TrialsUCB Reports Sustained Long‑Term Efficacy of Rozanolixizumab and Zilucopla... UCB Reports Sustained Long‑Term Efficacy of Rozanolixizumab and Zilucopla... Read Post »
Clinical TrialsMAIA Reports 90.5% Disease Control Rate with Ateganosine Plus Cemiplimab in... MAIA Reports 90.5% Disease Control Rate with Ateganosine Plus Cemiplimab in... Read Post »
Clinical TrialsKeenova’s XIAFLEX Delivers Positive Phase 3 Results in Plantar Fibrom... Keenova’s XIAFLEX Delivers Positive Phase 3 Results in Plantar Fibrom... Read Post »
Clinical TrialsSeres Reports Positive SER-155 Results in Immune Checkpoint Enterocolitis Seres Reports Positive SER-155 Results in Immune Checkpoint Enterocolitis Read Post »
New Drug ApprovalMHRA Approves Nerandomilast for Idiopathic Pulmonary Fibrosis and Progressi... MHRA Approves Nerandomilast for Idiopathic Pulmonary Fibrosis and Progressi... Read Post »
ResearchGalderma Global Survey Reveals Skin Quality Concerns Affect 90% of People, ... Galderma Global Survey Reveals Skin Quality Concerns Affect 90% of People, ... Read Post »
Clinical TrialsTurn Therapeutics Reports Interim Phase 2 Results, Finalizes Stage 2 Trial ... Turn Therapeutics Reports Interim Phase 2 Results, Finalizes Stage 2 Trial ... Read Post »
New Drug ApprovalFDA Grants Accelerated Approval to TRUTAKNA for IgA Nephropathy FDA Grants Accelerated Approval to TRUTAKNA for IgA Nephropathy Read Post »
New Drug ApprovalFDA Expands WILATE Prophylaxis Approval to Children Under 6 With von Willeb... FDA Expands WILATE Prophylaxis Approval to Children Under 6 With von Willeb... Read Post »
Clinical TrialsCompass Pathways Reports 6-Month Phase 3 Data Showing Durable COMP360 Benef... Compass Pathways Reports 6-Month Phase 3 Data Showing Durable COMP360 Benef... Read Post »
Clinical TrialsTeva Advances TEV-‘408 to Phase 2b After Early Vitiligo Trial Shows R... Teva Advances TEV-‘408 to Phase 2b After Early Vitiligo Trial Shows R... Read Post »
Clinical TrialsHengrui and Kailera’s Oral GLP-1 HRS-7535 Delivers Up to 11.1% Weight... Hengrui and Kailera’s Oral GLP-1 HRS-7535 Delivers Up to 11.1% Weight... Read Post »
Clinical TrialsTvardi Reports Positive Phase 1 Results for Oral STAT3 Inhibitor TTI-109 Tvardi Reports Positive Phase 1 Results for Oral STAT3 Inhibitor TTI-109 Read Post »
Clinical TrialsItalfarmaco Reports New Phase 3 EPIDYS MRI Data Showing Givinostat Preserve... Italfarmaco Reports New Phase 3 EPIDYS MRI Data Showing Givinostat Preserve... Read Post »
New Drug ApprovalEU Approves TEPKINLY Plus R2 as New Chemotherapy-Free Option for Follicular... EU Approves TEPKINLY Plus R2 as New Chemotherapy-Free Option for Follicular... Read Post »
Clinical TrialsTG Therapeutics Launches Phase 2 Trial of BRIUMVI in Treatment-Resistant Sc... TG Therapeutics Launches Phase 2 Trial of BRIUMVI in Treatment-Resistant Sc... Read Post »
ResearchExperimental IDH1 Vaccine Shows Encouraging 8-Year Survival in IDH-Mutant A... Experimental IDH1 Vaccine Shows Encouraging 8-Year Survival in IDH-Mutant A... Read Post »
New Drug ApprovalMHRA Approves Incyte’s Retifanlimab for Advanced Merkel Cell Carcinom... MHRA Approves Incyte’s Retifanlimab for Advanced Merkel Cell Carcinom... Read Post »
Clinical TrialsOpus Genetics Aligns with FDA on Phase 3 Trial Design for OPGx-LCA5 Opus Genetics Aligns with FDA on Phase 3 Trial Design for OPGx-LCA5 Read Post »
Clinical TrialsFDA Accepts Pharvaris’ Deucrictibant NDA for HAE FDA Accepts Pharvaris’ Deucrictibant NDA for HAE Read Post »
Drugs Safety AlertInvivyd Plans Full FDA Approval for COVID-19 as PEMGARDA EUA Faces 2027 Exp... Invivyd Plans Full FDA Approval for COVID-19 as PEMGARDA EUA Faces 2027 Exp... Read Post »
ResearchBeyond the Needle: How Oral Drug Delivery Is Redefining Modern Medicine Beyond the Needle: How Oral Drug Delivery Is Redefining Modern Medicine Read Post »
ResearchHow ADCs and Bispecific Antibodies Are Transforming Cancer Treatment How ADCs and Bispecific Antibodies Are Transforming Cancer Treatment Read Post »
ResearchWhy PD-1 Remains the Leading Target in Cancer Immunotherapy Why PD-1 Remains the Leading Target in Cancer Immunotherapy Read Post »
Clinical TrialsIndian Researchers at Tata Memorial Centre Show Papaya Leaf Extract Improve... Indian Researchers at Tata Memorial Centre Show Papaya Leaf Extract Improve... Read Post »
New Drug ApprovalMHRA Conditionally Approves Wegovy for MASH MHRA Conditionally Approves Wegovy for MASH Read Post »
New Drug ApprovalMHRA Authorises Inqlexzo Gemcitabine Delivery System for BCG-Unresponsive H... MHRA Authorises Inqlexzo Gemcitabine Delivery System for BCG-Unresponsive H... Read Post »
Clinical TrialsWHO Launches PARTNERS Trial to Evaluate MBP134 and Remdesivir for Bundibugy... WHO Launches PARTNERS Trial to Evaluate MBP134 and Remdesivir for Bundibugy... Read Post »
Clinical TrialsBrii Bio Reports Phase 2b Data Supporting Sequential BRII-179 Regimen for F... Brii Bio Reports Phase 2b Data Supporting Sequential BRII-179 Regimen for F... Read Post »
Clinical TrialsCould a Once-Daily Polypill Improve Heart Failure Outcomes? POLY-HF Trial S... Could a Once-Daily Polypill Improve Heart Failure Outcomes? POLY-HF Trial S... Read Post »
Clinical TrialsNeurocrine Moves Crinecerfont into Phase 2 Trial for Children Under 4 with ... Neurocrine Moves Crinecerfont into Phase 2 Trial for Children Under 4 with ... Read Post »
Clinical TrialsAcoramidis Associated with First-Ever Early and Sustained Direct Kidney-Pro... Acoramidis Associated with First-Ever Early and Sustained Direct Kidney-Pro... Read Post »
Clinical TrialsRevolution Medicines Reports Promising Phase 1/2 Results for Zoldonrasib Co... Revolution Medicines Reports Promising Phase 1/2 Results for Zoldonrasib Co... Read Post »
Clinical TrialsRoche’s Divarasib Shows Superiority in Head-to-Head Phase III Trial A... Roche’s Divarasib Shows Superiority in Head-to-Head Phase III Trial A... Read Post »
New Drug ApprovalEU Approves Novartis’ Itvisma as First Gene Replacement Therapy for C... EU Approves Novartis’ Itvisma as First Gene Replacement Therapy for C... Read Post »
